Regeneron Pharmaceuticals (REGN) Total Liabilities (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Total Liabilities came in at $9.4 billion in Q1 2026, up 15.78% year-on-year from $8.2 billion in Q1 2025, and up 1.54% quarter-over-quarter from $9.3 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Total Liabilities for 18 years, with the latest figure at $9.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 15.78% year-over-year to $9.4 billion; the trailing twelve-month figure through Mar 2026 stood at $9.4 billion (up 15.78% YoY), and the FY2025 full-year result was $9.3 billion, up 10.66% from the prior year.
- Total Liabilities for Q1 2026 stood at $9.4 billion, up from $9.3 billion in the prior quarter.
- The five-year high for Total Liabilities was $9.4 billion in Q1 2026, with the low at $6.2 billion in Q3 2022.
- Average Total Liabilities over 5 years is $7.6 billion, with a median of $7.4 billion recorded in 2024.
- Year-over-year, Total Liabilities declined 2.72% in 2022 and gained 18.7% in 2024.
- Tracing REGN's Total Liabilities over 5 years: stood at $6.6 billion in 2022, then advanced by 8.5% to $7.1 billion in 2023, then increased by 18.27% to $8.4 billion in 2024, then climbed by 10.66% to $9.3 billion in 2025, then advanced by 1.54% to $9.4 billion in 2026.
- The last three Total Liabilities figures came in at $9.4 billion (Q1 2026), $9.3 billion (Q4 2025), and $9.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 753.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.45 Bn |
| Dec 31, 2025 | 9.30 Bn |
| Sep 30, 2025 | 9.21 Bn |
| Jun 30, 2025 | 8.28 Bn |
| Mar 31, 2025 | 8.16 Bn |
| Dec 31, 2024 | 8.41 Bn |
| Sep 30, 2024 | 8.12 Bn |
| Jun 30, 2024 | 7.88 Bn |
| Mar 31, 2024 | 7.38 Bn |
| Dec 31, 2023 | 7.11 Bn |
| Sep 30, 2023 | 7.26 Bn |
| Jun 30, 2023 | 6.64 Bn |
| Mar 31, 2023 | 6.56 Bn |
| Dec 31, 2022 | 6.55 Bn |
| Sep 30, 2022 | 6.24 Bn |
| Jun 30, 2022 | 6.52 Bn |
| Mar 31, 2022 | 6.43 Bn |
| Dec 31, 2021 | 6.67 Bn |
| Sep 30, 2021 | 6.41 Bn |
| Jun 30, 2021 | 6.36 Bn |
| Mar 31, 2021 | 5.80 Bn |
| Dec 31, 2020 | 6.14 Bn |
| Sep 30, 2020 | 5.96 Bn |
| Jun 30, 2020 | 5.37 Bn |
| Mar 31, 2020 | 3.62 Bn |
| Dec 31, 2019 | 3.72 Bn |
| Sep 30, 2019 | 3.43 Bn |
| Jun 30, 2019 | 3.42 Bn |
| Mar 31, 2019 | 3.41 Bn |
| Dec 31, 2018 | 2.98 Bn |
| Sep 30, 2018 | 2.94 Bn |
| Jun 30, 2018 | 2.77 Bn |
| Mar 31, 2018 | 2.81 Bn |
| Dec 31, 2017 | 2.62 Bn |
| Sep 30, 2017 | 2.65 Bn |
| Jun 30, 2017 | 2.59 Bn |
| Mar 31, 2017 | 2.95 Bn |
| Dec 31, 2016 | 2.52 Bn |
| Sep 30, 2016 | 2.34 Bn |
| Jun 30, 2016 | 2.13 Bn |
| Mar 31, 2016 | 2.14 Bn |
| Dec 31, 2015 | 1.95 Bn |
| Sep 30, 2015 | 1.89 Bn |
| Jun 30, 2015 | 1.19 Bn |
| Mar 31, 2015 | 1.23 Bn |
| Dec 31, 2014 | 1.29 Bn |
| Sep 30, 2014 | 1.19 Bn |
| Jun 30, 2014 | 1.09 Bn |
| Mar 31, 2014 | 1.05 Bn |
| Dec 31, 2013 | 998.94 Mn |
| Sep 30, 2013 | 950.24 Mn |
| Jun 30, 2013 | 884.92 Mn |
| Mar 31, 2013 | 869.65 Mn |
| Dec 31, 2012 | 835.11 Mn |
| Sep 30, 2012 | 854.59 Mn |
| Jun 30, 2012 | 862.84 Mn |
| Mar 31, 2012 | 846.14 Mn |
| Dec 31, 2011 | 837.85 Mn |
| Sep 30, 2011 | 554.78 Mn |
| Jun 30, 2011 | 568.83 Mn |
| Mar 31, 2011 | 556.20 Mn |
| Dec 31, 2010 | 561.62 Mn |
| Sep 30, 2010 | 594.37 Mn |
| Jun 30, 2010 | 419.43 Mn |
| Mar 31, 2010 | -386.27 Mn |
| Dec 31, 2009 | 344.44 Mn |
| Sep 30, 2009 | -422.44 Mn |
| Jun 30, 2009 | -410.51 Mn |